Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.

Explorateur d’archives

Parcourir et rechercher des captures

Note importante

Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.

Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.

Parcourir les sites archivés

Parcourir toutes les sources →

Archived 21: National Advisory Committee on Immunization statement: Interim guidance on booster COVID-19 vaccine doses in Canada [2021-10-29] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 21: National Advisory Committee on Immunization statement: Interim guidance on booster COVID-19 vaccine doses in Canada [2021-10-29] - Canada.ca We have archived this page and will not be updating it. You can use it for…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines/statement-guidance-booster-doses.html

Archived 24: Summary of National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5 to 11 years of age [2021-11-19] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 24: Summary of National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5 to 11 years of age [2021-11-19] - Canada.ca We have…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines/pfizer-biontech-10-mcg-children-5-11-years-age/summary.html

Archive 22: Recommendations on the use of COVID-19 vaccines [2021-10-22] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archive 22: Recommendations on the use of COVID-19 vaccines [2021-10-22] - Canada.ca We have archived this page and will not be updating it. You can use it for research or reference. Français fr / Gouvernement du…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines.html

Archived 24: National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5 to 11 years of age [2021-11-19] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 24: National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5 to 11 years of age [2021-11-19] - Canada.ca We have archived this…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines/pfizer-biontech-10-mcg-children-5-11-years-age.html

Archived 29: Summary of NACI statement of January 25, 2022: Updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age [2022-01-25] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 29: Summary of NACI statement of January 25, 2022: Updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age [2022-01-25] - Canada.ca We have archived this page and will not be updating it.…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/updated-recommendations-use-covid-19-vaccines-children-5-11-years-age/summary.html

Archived 29: Amendment to January 25, 2022: NACI updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 29: Amendment to January 25, 2022: NACI updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age - Canada.ca We have archived this page and will not be updating it. You can use it for…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/updated-recommendations-use-covid-19-vaccines-children-5-11-years-age/amendment-january-25-2022.html

Archived 29: NACI updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age [2022-01-25] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 29: NACI updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age [2022-01-25] - Canada.ca We have archived this page and will not be updating it. You can use it for research or reference.…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/updated-recommendations-use-covid-19-vaccines-children-5-11-years-age.html

Archived 25: Summary of NACI rapid response of December 3, 2021: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 25: Summary of NACI rapid response of December 3, 2021: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 - Canada.ca Skip to main…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/rapid-response-recommendation-use-covid-19-vaccines-individuals-aged-12-years-older-myocarditis-pericarditis-reported-following-mrna-vaccines/summary.html

Archived 25: NACI rapid response: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 vaccines [2021-12-03] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 25: NACI rapid response: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 vaccines [2021-12-03] - Canada.ca Skip…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/rapid-response-recommendation-use-covid-19-vaccines-individuals-aged-12-years-older-myocarditis-pericarditis-reported-following-mrna-vaccines.html

Archived 26: NACI updated guidance on booster COVID-19 vaccine doses in Canada [2021-12-03] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 26: NACI updated guidance on booster COVID-19 vaccine doses in Canada [2021-12-03] - Canada.ca We have archived this page and will not be updating it. You can use it for research or reference. Français fr…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-booster-covid-19-vaccine-doses.html
Page 3917 sur 3977Affichage de 39161 à 39170 sur 39762
« Première← Préc.Suiv. →Dernière »

Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.